These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30746066)

  • 1. Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst
    Daryaei I; Sandoval K; Witt K; Kontoyianni M; Michael Crider A
    Medchemcomm; 2018 Dec; 9(12):2083-2090. PubMed ID: 30746066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.
    Neumann WL; Sandoval KE; Mobayen S; Minaeian M; Kukielski SG; Srabony KN; Frare R; Slater O; Farr SA; Niehoff ML; Hospital A; Kontoyianni M; Crider AM; Witt KA
    RSC Med Chem; 2021 Aug; 12(8):1352-1365. PubMed ID: 34458738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule somatostatin receptor subtype 4 (sst
    Szőke É; Bálint M; Hetényi C; Markovics A; Elekes K; Pozsgai G; Szűts T; Kéri G; Őrfi L; Sándor Z; Szolcsányi J; Pintér E; Helyes Z
    Neuropharmacology; 2020 Nov; 178():108198. PubMed ID: 32739276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors.
    Alam MS; Huang J; Ozoe F; Matsumura F; Ozoe Y
    Bioorg Med Chem; 2007 Aug; 15(15):5090-104. PubMed ID: 17544280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-pyridylthioureas: novel nonpeptide somatostatin agonists with SST4 selectivity.
    Liu S; Crider AM; Tang C; Ho B; Ankersen M; Stidsen CE
    Curr Pharm Des; 1999 Apr; 5(4):255-63. PubMed ID: 10101224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
    J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
    Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
    J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kántás B; Szőke É; Börzsei R; Bánhegyi P; Asghar J; Hudhud L; Steib A; Hunyady Á; Horváth Á; Kecskés A; Borbély É; Hetényi C; Pethő G; Pintér E; Helyes Z
    Front Pharmacol; 2020; 11():601887. PubMed ID: 33815096
    [No Abstract]   [Full Text] [Related]  

  • 12. The heptapeptide somatostatin analogue TT-232 exerts analgesic and anti-inflammatory actions via SST
    Börzsei R; Borbély É; Kántás B; Hudhud L; Horváth Á; Szőke É; Hetényi C; Helyes Z; Pintér E
    Biochem Pharmacol; 2023 Mar; 209():115419. PubMed ID: 36693436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas.
    Liu S; Tang C; Ho B; Ankersen M; Stidsen CE; Crider AM
    J Med Chem; 1998 Nov; 41(24):4693-705. PubMed ID: 9822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.
    Kántás B; Börzsei R; Szőke É; Bánhegyi P; Horváth Á; Hunyady Á; Borbély É; Hetényi C; Pintér E; Helyes Z
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses.
    Engström M; Savola JM; Wurster S
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1262-8. PubMed ID: 16291731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
    Reubi JC; Schär JC; Waser B; Wenger S; Heppeler A; Schmitt JS; Mäcke HR
    Eur J Nucl Med; 2000 Mar; 27(3):273-82. PubMed ID: 10774879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
    Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.